TickerFacts.

Bioadaptives, Inc. (BDPT): Operating Cash Flow

Annual figures by period end, from SEC filings.

-$516.0K
Year ended 2025-12-31
-$436.4K
Trailing 12 months to 2026-06-30
2014-12-31: -$58.6K2015-12-31: -$722018-12-31: -$420.1K2019-12-31: -$168.1K2020-12-31: -$106.9K2021-12-31: -$158.7K2022-12-31: -$227.3K2023-12-31: -$223.8K2024-12-31: -$249.5K2025-12-31: -$516.0K-$516.0K
2014-12-31 Operating Cash Flow (USD) 2025-12-31
Period endedOperating Cash FlowChange YoYSource filing
2025-12-31-$516.0Kn/m2026-04-14, From 2025-01-01
2024-12-31-$249.5Kn/m2026-04-14, From 2024-01-01
2023-12-31-$223.8Kn/m2025-04-15, From 2023-01-01
2022-12-31-$227.3Kn/m2024-04-10, From 2022-01-01
2021-12-31-$158.7Kn/m2023-03-31, From 2021-01-01
2020-12-31-$106.9Kn/m2022-03-31, From 2020-01-01
2019-12-31-$168.1Kn/m2021-03-30, From 2019-01-01
2018-12-31-$420.1Kn/a2020-05-12, From 2018-01-01
No annual figure between 2015-12-31 and 2018-12-31.
2015-12-31-$72n/m2016-04-14, From 2015-01-01
2014-12-31-$58.6Kn/a2016-04-14, From 2014-01-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
Bioadaptives, Inc. (BDPT)2025-12-31-$516.0Kn/m
PRF Technologies Ltd. (PRFX)2025-12-31-$3.96Mn/m
Skinvisible, Inc. (SKVI)2025-12-31-$38.4Kn/m
Jupiter Neurosciences, Inc. (JUNS)2025-12-31-$5.41Mn/m
Talphera, Inc. (TLPH)2025-12-31-$11.36Mn/m
Impact Biomedical Inc. (IBO)2025-12-31-$1.89Mn/m
Lyell Immunopharma, Inc. (LYEL)2025-12-31-$150.02Mn/m
Neonc Technologies Holdings, Inc. (NTHI)2025-12-31-$20.36Mn/m
Altimmune, Inc. (ALT)2025-12-31-$67.53Mn/m

Compare BDPT, PRFX, SKVI, JUNS side by side · Screen every company in Pharmaceutical Preparations ↗